[go: up one dir, main page]

AU2001248199A1 - Crystal structure for rmlc and uses thereof - Google Patents

Crystal structure for rmlc and uses thereof

Info

Publication number
AU2001248199A1
AU2001248199A1 AU2001248199A AU4819901A AU2001248199A1 AU 2001248199 A1 AU2001248199 A1 AU 2001248199A1 AU 2001248199 A AU2001248199 A AU 2001248199A AU 4819901 A AU4819901 A AU 4819901A AU 2001248199 A1 AU2001248199 A1 AU 2001248199A1
Authority
AU
Australia
Prior art keywords
rmlc
crystal structure
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248199A
Inventor
Alexei Bochkarev
Dinesh Christendat
Aled M. Edwards
Emil F. Pai
Vivian Saridakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Health Network
Original Assignee
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network filed Critical University Health Network
Publication of AU2001248199A1 publication Critical patent/AU2001248199A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001248199A 2000-04-13 2001-04-12 Crystal structure for rmlc and uses thereof Abandoned AU2001248199A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19691500P 2000-04-13 2000-04-13
US60/196,915 2000-04-13
PCT/CA2001/000512 WO2001079457A2 (en) 2000-04-13 2001-04-12 Crystal structure for rmlc and uses thereof

Publications (1)

Publication Number Publication Date
AU2001248199A1 true AU2001248199A1 (en) 2001-10-30

Family

ID=22727266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248199A Abandoned AU2001248199A1 (en) 2000-04-13 2001-04-12 Crystal structure for rmlc and uses thereof

Country Status (2)

Country Link
AU (1) AU2001248199A1 (en)
WO (1) WO2001079457A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044185A2 (en) * 2001-11-21 2003-05-30 Affinium Pharmaceuticals, Inc. Purified polypeptides involved in general metabolism
CN113930353B (en) * 2021-08-31 2023-07-07 广西大学 A kind of selenite-resistant Serratia marcescens and its reducing characteristic identification method

Also Published As

Publication number Publication date
WO2001079457A3 (en) 2002-09-06
WO2001079457A2 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2001241695A1 (en) Dichroic polarizer and material
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001248817A1 (en) Form panel and panel holding member
AU2001287888A1 (en) Alerting device
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AUPQ872300A0 (en) Compounds and methods
AU2001235363A1 (en) Mibefradil analogues and their use
AU2001278951A1 (en) Compounds and methods
AU2002244345A1 (en) Liquid-crystal display
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AUPQ526100A0 (en) Improvements in single use syringes
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof